Compounds > bumetanide
Page last updated: 2024-10-23

bumetanide and Drug-Induced Cochlear Toxicity

bumetanide has been researched along with Drug-Induced Cochlear Toxicity in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Bumetanide, an inhibitor of the sodium-potassium-chloride cotransporter-1, has been suggested as an adjunct to phenobarbital for treating neonatal seizures."9.41Effects of bumetanide on neonatal seizures: A systematic review of animal and human studies. ( Athikarisamy, S; Farhat, A; Ghosh, S; Nagarajan, L; Rakshasbhuvankar, A; Rao, S, 2023)
"Bumetanide, an inhibitor of the sodium-potassium-chloride cotransporter-1, has been suggested as an adjunct to phenobarbital for treating neonatal seizures."5.41Effects of bumetanide on neonatal seizures: A systematic review of animal and human studies. ( Athikarisamy, S; Farhat, A; Ghosh, S; Nagarajan, L; Rakshasbhuvankar, A; Rao, S, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rao, S1
Farhat, A1
Rakshasbhuvankar, A1
Athikarisamy, S1
Ghosh, S1
Nagarajan, L1

Reviews

1 review available for bumetanide and Drug-Induced Cochlear Toxicity

ArticleYear
Effects of bumetanide on neonatal seizures: A systematic review of animal and human studies.
    Seizure, 2023, Volume: 111

    Topics: Aminoglycosides; Animals; Anticonvulsants; Bumetanide; Epilepsy; Hearing Loss; Humans; Infant; Infan

2023